Publicacións en colaboración con investigadores/as de Guy's Hospital (26)

2024

  1. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

    Nature Communications, Vol. 15, Núm. 1

  2. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models

    Nature Communications , Vol. 15, Núm. 1

2023

  1. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

    The Lancet Haematology, Vol. 10, Núm. 5, pp. e367-e381

  2. European Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission

    The Lancet Oncology, Vol. 24, Núm. 1, pp. e11-e56

2022

  1. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

    ESMO Open, Vol. 7, Núm. 2

  2. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy

    Breast, Vol. 63, pp. 123-139

  3. Text mining and word embedding for classification of decision making variables in breast cancer surgery

    European Journal of Surgical Oncology, Vol. 48, Núm. 7, pp. 1503-1509

  4. The International Association for the Study of Lung Cancer Thymic Epithelial Tumor Staging Project: Unresolved Issues to be Addressed for the Next Ninth Edition of the TNM Classification of Malignant Tumors

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 838-851

2021

  1. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox

    The Lancet Oncology, Vol. 22, Núm. 1, pp. e18-e28

  2. Elective Cancer Surgery in COVID-19-Free Surgical Pathways during the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

    Journal of Clinical Oncology, Vol. 39, Núm. 1, pp. 66-78

  3. Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)

    American Journal of Hematology, Vol. 96, Núm. 1, pp. 69-79

  4. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis

    Chest, Vol. 159, Núm. 3, pp. 1182-1196

  5. KarMMa-RW: comparison of idecabtagene vicleucel with real-world outcomes in relapsed and refractory multiple myeloma

    Blood Cancer Journal, Vol. 11, Núm. 6

2020

  1. Oncoplastic Breast Surgery Techniques for the General Surgeon

    Springer International Publishing, pp. 1-635

  2. Preface

    Oncoplastic Breast Surgery Techniques for the General Surgeon

2019

  1. About the French prohibition of textured breast implants: is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position

    Breast

  2. Corrigendum to “About the French prohibition of textured breast implants: Is it justified or over-cautious? The EUSOMA, ESSO/BRESSO position” (The Breast (2019) 46 (95–96), (S0960977619304990), (10.1016/j.breast.2019.05.005))

    Breast

  3. European Society of Surgical Oncology's strategy for clinical research: Paving the way for a culture of research in cancer surgery

    European Journal of Surgical Oncology, Vol. 45, Núm. 9, pp. 1515-1519

2017

  1. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    The Lancet, Vol. 390, Núm. 10094, pp. 555-566

2016

  1. Breast cancer

    Surgical Oncology: Theory and Multidisciplinary Practice, Second Edition (CRC Press), pp. 197-248